These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36747619)

  • 1. Germline pathogenic variants in 786 neuroblastoma patients.
    Kim J; Vaksman Z; Egolf LE; Kaufman R; Evans JP; Conkrite KL; Danesh A; Lopez G; Randall MP; Dent MH; Farra LM; Menghani N; Dymek M; Desai H; Hausler R; ; ; ; Auvil JG; Gerhard DS; Hakonarson H; Maxwell KN; Cole KA; Pugh TJ; Bosse KR; Khan J; Wei JS; Maris JM; Stewart DR; Diskin SJ
    medRxiv; 2023 Jan; ():. PubMed ID: 36747619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival.
    Kim J; Vaksman Z; Egolf LE; Kaufman R; Evans JP; Conkrite KL; Danesh A; Lopez G; Randall MP; Dent MH; Farra LM; Menghani NL; Dymek M; Desai H; Hausler R; Hicks B; Auvil JG; Gerhard DS; Hakonarson H; Maxwell KN; Cole KA; Pugh TJ; Bosse KR; Khan J; Wei JS; Maris JM; Stewart DR; Diskin SJ
    J Natl Cancer Inst; 2024 Jan; 116(1):149-159. PubMed ID: 37688579
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Randall MP; Egolf LE; Vaksman Z; Samanta M; Tsang M; Groff D; Evans JP; Rokita JL; Layeghifard M; Shlien A; Maris JM; Diskin SJ; Bosse KR
    bioRxiv; 2023 Feb; ():. PubMed ID: 36778420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative Analysis of Germline Rare Variants in Clear and Non-Clear Cell Renal Cell Carcinoma.
    Han S; Camp SY; Chu H; Collins R; Gillani R; Park J; Bakouny Z; Ricker CA; Reardon B; Moore N; Kofman E; Labaki C; Braun D; Choueiri TK; AlDubayan SH; Van Allen EM
    medRxiv; 2023 Jan; ():. PubMed ID: 36712083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare germline variants in childhood cancer patients suspected of genetic predisposition to cancer.
    Sylvester DE; Chen Y; Grima N; Saletta F; Padhye B; Bennetts B; Wright D; Krivanek M; Graf N; Zhou L; Catchpoole D; Kirk J; Latchoumanin O; Qiao L; Ballinger M; Thomas D; Jamieson R; Dalla-Pozza L; Byrne JA
    Genes Chromosomes Cancer; 2022 Feb; 61(2):81-93. PubMed ID: 34687117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BARD1 germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma.
    Randall MP; Egolf LE; Vaksman Z; Samanta M; Tsang M; Groff D; Evans JP; Rokita JL; Layeghifard M; Shlien A; Maris JM; Diskin SJ; Bosse KR
    J Natl Cancer Inst; 2024 Jan; 116(1):138-148. PubMed ID: 37688570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inherited rare variants in homologous recombination and neurodevelopmental genes are associated with increased risk of neuroblastoma.
    Bonfiglio F; Lasorsa VA; Cantalupo S; D'Alterio G; Aievola V; Boccia A; Ardito M; Furini S; Renieri A; Morini M; Stainczyk S; Westermann F; Paolella G; Eva A; Iolascon A; Capasso M
    EBioMedicine; 2023 Jan; 87():104395. PubMed ID: 36493725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Landscape of Pathogenic or Likely Pathogenic Germline Variants and Their Association With Somatic Phenotype in Unselected Chinese Patients With Gynecologic Cancers.
    Wen H; Xu Q; Sheng X; Li H; Wang X; Wu X
    JAMA Netw Open; 2023 Jul; 6(7):e2326437. PubMed ID: 37523182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDH1 Genotype Exploration in Women With Hereditary Lobular Breast Cancer Phenotype.
    Corso G; Marino E; Zanzottera C; Oliveira C; Bernard L; Macis D; Figueiredo J; Pereira J; Carneiro P; Massari G; Barberis M; De Scalzi AM; Taormina SV; Sajjadi E; Sangalli C; Gandini S; D'Ecclesiis O; Trovato CM; Rotili A; Pesapane F; Nicosia L; La Vecchia C; Galimberti V; Guerini-Rocco E; Bonanni B; Veronesi P
    JAMA Netw Open; 2024 Apr; 7(4):e247862. PubMed ID: 38652475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline 16p11.2 Microdeletion Predisposes to Neuroblastoma.
    Egolf LE; Vaksman Z; Lopez G; Rokita JL; Modi A; Basta PV; Hakonarson H; Olshan AF; Diskin SJ
    Am J Hum Genet; 2019 Sep; 105(3):658-668. PubMed ID: 31474320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non-Muscle-Invasive Bladder Cancer.
    Pietzak EJ; Whiting K; Srinivasan P; Bandlamudi C; Khurram A; Joseph V; Walasek A; Bochner E; Clinton T; Almassi N; Truong H; de Jesus Escano MR; Wiseman M; Mandelker D; Kemel Y; Zhang L; Walsh MF; Cadoo KA; Coleman JA; Al-Ahmadie H; Rosenberg JE; Iyer GV; Solit DB; Ostrovnaya I; Offit K; Robson ME; Stadler ZK; Berger MF; Bajorin DF; Carlo M; Bochner BH
    Clin Cancer Res; 2022 Oct; 28(19):4267-4277. PubMed ID: 35833951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative Analysis of Germline Rare Variants in Clear and Non-clear Cell Renal Cell Carcinoma.
    Han SH; Camp SY; Chu H; Collins R; Gillani R; Park J; Bakouny Z; Ricker CA; Reardon B; Moore N; Kofman E; Labaki C; Braun D; Choueiri TK; AlDubayan SH; Van Allen EM
    Eur Urol Open Sci; 2024 Apr; 62():107-122. PubMed ID: 38496821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing the Diagnostic Yield of Germline Exome Versus Panel Sequencing in the Diverse Population of the Texas KidsCanSeq Pediatric Cancer Study.
    Desrosiers-Battu LR; Wang T; Reuther J; Miles G; Dai H; Jo E; Russell H; Raesz-Martinez R; Recinos A; Gutierrez S; Thomas A; Berenson E; Corredor J; Nugent K; Wyatt Castillo R; Althaus R; Littlejohn R; Gessay S; Tomlinson G; Gill J; Bernini JC; Vallance K; Griffin T; Scollon S; Lin FY; Eng C; Kulkarni S; Hilsenbeck SG; Roy A; McGuire AL; Parsons DW; Plon SE
    JCO Precis Oncol; 2024 Sep; 8():e2400187. PubMed ID: 39259914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in the Childhood Cancer Survivor Study.
    Kim J; Gianferante M; Karyadi DM; Hartley SW; Frone MN; Luo W; Robison LL; Armstrong GT; Bhatia S; Dean M; Yeager M; Zhu B; Song L; Sampson JN; Yasui Y; Leisenring WM; Brodie SA; de Andrade KC; Fortes FP; Goldstein AM; Khincha PP; Machiela MJ; McMaster ML; Nickerson ML; Oba L; Pemov A; Pinheiro M; Rotunno M; Santiago K; Wegman-Ostrosky T; Diver WR; Teras L; Freedman ND; Hicks BD; Zhu B; Wang M; Jones K; Hutchinson AA; Dagnall C; Savage SA; Tucker MA; Chanock SJ; Morton LM; Stewart DR; Mirabello L
    JNCI Cancer Spectr; 2021 Apr; 5(2):. PubMed ID: 34308104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma.
    Mirabello L; Zhu B; Koster R; Karlins E; Dean M; Yeager M; Gianferante M; Spector LG; Morton LM; Karyadi D; Robison LL; Armstrong GT; Bhatia S; Song L; Pankratz N; Pinheiro M; Gastier-Foster JM; Gorlick R; de Toledo SRC; Petrilli AS; Patino-Garcia A; Lecanda F; Gutierrez-Jimeno M; Serra M; Hattinger C; Picci P; Scotlandi K; Flanagan AM; Tirabosco R; Amary MF; Kurucu N; Ilhan IE; Ballinger ML; Thomas DM; Barkauskas DA; Mejia-Baltodano G; Valverde P; Hicks BD; Zhu B; Wang M; Hutchinson AA; Tucker M; Sampson J; Landi MT; Freedman ND; Gapstur S; Carter B; Hoover RN; Chanock SJ; Savage SA
    JAMA Oncol; 2020 May; 6(5):724-734. PubMed ID: 32191290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Germline Alterations on Targeted Tumor-Normal Sequencing of Esophagogastric Cancer.
    Ku GY; Kemel Y; Maron SB; Chou JF; Ravichandran V; Shameer Z; Maio A; Won ES; Kelsen DP; Ilson DH; Capanu M; Strong VE; Molena D; Sihag S; Jones DR; Coit DG; Tuvy Y; Cowie K; Solit DB; Schultz N; Hechtman JF; Offit K; Joseph V; Mandelker D; Janjigian YY; Stadler ZK
    JAMA Netw Open; 2021 Jul; 4(7):e2114753. PubMed ID: 34251444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline Sequencing DNA Repair Genes in 5545 Men With Aggressive and Nonaggressive Prostate Cancer.
    Darst BF; Dadaev T; Saunders E; Sheng X; Wan P; Pooler L; Xia LY; Chanock S; Berndt SI; Gapstur SM; Stevens V; Albanes D; Weinstein SJ; Gnanapragasam V; Giles GG; Nguyen-Dumont T; Milne RL; Pomerantz M; Schmidt JA; Mucci L; Catalona WJ; Hetrick KN; Doheny KF; MacInnis RJ; Southey MC; Eeles RA; Wiklund F; Kote-Jarai Z; Conti DV; Haiman CA
    J Natl Cancer Inst; 2021 May; 113(5):616-625. PubMed ID: 32853339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline Testing Identifies Pathogenic/Likely Pathogenic Variants in Patients with Pancreatic Neuroendocrine Tumors.
    Mohindroo C; Baydogan S; Agarwal P; Wright RD; Prakash LR; Mork ME; Klein AP; Laheru DA; Maxwell JE; Katz MHG; Dasari A; Kim MP; He J; McAllister F; De Jesus-Acosta A
    Cancer Prev Res (Phila); 2024 Jul; 17(7):335-342. PubMed ID: 38662083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline Variants Incidentally Detected via Tumor-Only Genomic Profiling of Patients With Mesothelioma.
    Mitchell OD; Gilliam K; Del Gaudio D; McNeely KE; Smith S; Acevedo M; Gaduraju M; Hodge R; Ramsland ASS; Segal J; Das S; Hathaway F; Bryan DS; Tawde S; Galasinski S; Wang P; Tjota MY; Husain AN; Armato SG; Donington J; Ferguson MK; Turaga K; Churpek JE; Kindler HL; Drazer MW
    JAMA Netw Open; 2023 Aug; 6(8):e2327351. PubMed ID: 37556141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic Germline Variants in Cancer Susceptibility Genes in Children and Young Adults With Rhabdomyosarcoma.
    Kim J; Light N; Subasri V; Young EL; Wegman-Ostrosky T; Barkauskas DA; Hall D; Lupo PJ; Patidar R; Maese LD; Jones K; Wang M; Tavtigian SV; Wu D; Shlien A; Telfer F; Goldenberg A; Skapek SX; Wei JS; Wen X; Catchpoole D; Hawkins DS; Schiffman JD; Khan J; Malkin D; Stewart DR
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34095712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.